Pfizer (NYSE: PFE) director granted 7,686 phantom stock units as deferred pay

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

BLAYLOCK RONALD E reported acquisition or exercise transactions in this Form 4 filing.

Pfizer director Ronald E. Blaylock received a grant of 7,686.539 Phantom Stock Units linked to Pfizer common stock. The units, valued using a reference price of $26.67 per unit, increase his total phantom stock holdings to 84,012.660 units. Each unit represents one phantom share and was granted under Pfizer’s Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. This award represents deferred director compensation that will be settled in cash or common stock, at his election, after he retires from the Board.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BLAYLOCK RONALD E

Role null

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	7,686.539	$26.67	$205K

Holdings After Transaction: Phantom Stock Units — 84,012.66 shares (Direct, null)

Footnotes (1)

Each unit represents one phantom share of common stock. Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Key Figures

Phantom units granted: 7,686.539 units Reference price per unit: $26.6700 per unit Total phantom units after grant: 84,012.660 units +1 more

4 metrics

Phantom units granted 7,686.539 units Grant on 2026-04-23 to director Ronald E. Blaylock

Reference price per unit $26.6700 per unit Price used for the 7,686.539 Phantom Stock Units grant

Total phantom units after grant 84,012.660 units Director Ronald E. Blaylock’s phantom stock balance after transaction

Underlying common stock link 1 unit = 1 phantom share Each Phantom Stock Unit represents one phantom share of common stock

Key Terms

Phantom Stock Units, Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors, deferred director's compensation

3 terms

Phantom Stock Units financial

"Each unit represents one phantom share of common stock."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors financial

"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."

deferred director's compensation financial

"These units represent deferred director's compensation that are settled in cash or common stock"

Form 4 Insider Transactions: What Each Field Means →

04/27/2026 - 06:37 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BLAYLOCK RONALD E

(Last)

(First)

(Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK

10001-2192

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Phantom Stock Units	⁽¹⁾	04/23/2026		A		7,686.539⁽²⁾		⁽³⁾	⁽³⁾	Common Stock	7,686.539	$26.67	84,012.66	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

3. These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

	/s/ Shanice A. Reid, by power of atty., for Ronald E. Blaylock	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Pfizer (PFE) report for Ronald E. Blaylock?

Pfizer reported that director Ronald E. Blaylock received 7,686.539 Phantom Stock Units. These units are a form of deferred director compensation linked to Pfizer common stock and were granted under Pfizer’s Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

How many phantom stock units does Ronald E. Blaylock hold after this Pfizer (PFE) grant?

After the latest grant, Ronald E. Blaylock holds a total of 84,012.660 Phantom Stock Units. This figure reflects his updated phantom stock balance as reported, combining the new 7,686.539-unit grant with his prior holdings under the same compensation framework.

What does each Pfizer (PFE) Phantom Stock Unit represent for Ronald E. Blaylock?

Each Phantom Stock Unit represents one phantom share of Pfizer common stock. While not an actual share, the unit tracks the value of a share and is used as a deferred compensation vehicle for non-employee directors under Pfizer’s established compensation and unit award plan.

Under which plan were Ronald E. Blaylock’s Pfizer (PFE) phantom units granted?

The phantom units were granted under the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. This plan provides equity-linked units as compensation, allowing directors to defer value tied to Pfizer common stock over time as part of their board service.

How and when are Ronald E. Blaylock’s Pfizer (PFE) phantom units settled?

The phantom units represent deferred director compensation that is settled after Ronald E. Blaylock retires from Pfizer’s Board. At that time, he can elect to receive settlement in either cash or Pfizer common stock, based on the plan’s terms and his chosen form of payment.